These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

106 related articles for article (PubMed ID: 30133803)

  • 1. Role of phenol red in the stabilization of the Sabin type 2 inactivated polio vaccine at various pH values.
    Huijuan Y; Xiaohu D; Ze L; Wei C; Jian Z; Lei M; Shaohui S; Weidong L; Guoyang L
    J Med Virol; 2019 Jan; 91(1):22-30. PubMed ID: 30133803
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Structure and immunogenicity of experimental foot-and-mouth disease and poliomyelitis vaccines.
    Twomey T; Newman J; Burrage T; Piatti P; Lubroth J; Brown F
    Vaccine; 1995 Nov; 13(16):1603-10. PubMed ID: 8578849
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Antigenic and immunogenic properties of inactivated polio vaccine made from Sabin strains.
    Kersten G; Hazendonk T; Beuvery C
    Vaccine; 1999 Apr; 17(15-16):2059-66. PubMed ID: 10217607
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Urea Improves Stability of Inactivated Polio Vaccine Serotype 3 During Lyophilization and Storage in Dried Formulations.
    Qi W; Orgel S; Francon A; Randolph TW; Carpenter JF
    J Pharm Sci; 2018 Aug; 107(8):2070-2078. PubMed ID: 29709487
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Physicochemical Characterization of Sabin Inactivated Poliovirus Vaccine for Process Development.
    Torisu T; Shikama S; Nakamura K; Enomoto K; Maruno T; Mori A; Uchiyama S; Satou T
    J Pharm Sci; 2021 May; 110(5):2121-2129. PubMed ID: 33340531
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Development of Thermostable Lyophilized Sabin Inactivated Poliovirus Vaccine.
    Shin WJ; Hara D; Gbormittah F; Chang H; Chang BS; Jung JU
    mBio; 2018 Nov; 9(6):. PubMed ID: 30482835
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Incompatibility of lyophilized inactivated polio vaccine with liquid pentavalent whole-cell-pertussis-containing vaccine.
    Kraan H; Ten Have R; van der Maas L; Kersten G; Amorij JP
    Vaccine; 2016 Aug; 34(38):4572-4578. PubMed ID: 27470209
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Community transmission of type 2 poliovirus after cessation of trivalent oral polio vaccine in Bangladesh: an open-label cluster-randomised trial and modelling study.
    Taniuchi M; Famulare M; Zaman K; Uddin MJ; Upfill-Brown AM; Ahmed T; Saha P; Haque R; Bandyopadhyay AS; Modlin JF; Platts-Mills JA; Houpt ER; Yunus M; Petri WA
    Lancet Infect Dis; 2017 Oct; 17(10):1069-1079. PubMed ID: 28693854
    [TBL] [Abstract][Full Text] [Related]  

  • 9. An inactivated poliovirus vaccine using Sabin strains produced on the serum-free PER.C6® cell culture platform is immunogenic and safe in a non-human primate model.
    Bockstal V; Tiemessen MM; Achterberg R; Van Wordragen C; Knaapen AM; Serroyen J; Marissen WE; Schuitemaker H; Zahn R
    Vaccine; 2018 Nov; 36(46):6979-6987. PubMed ID: 30314910
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Preformulation study of highly purified inactivated polio vaccine, serotype 3.
    Qi W; Zeng Y; Orgel S; Francon A; Kim JH; Randolph TW; Carpenter JF; Middaugh CR
    J Pharm Sci; 2014 Jan; 103(1):140-51. PubMed ID: 24282078
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Immunogenicity of sabin inactivated poliovirus vaccine induced by diphtheria-tetanus-acellular pertussis and Sabin inactivated poliovirus combined vaccine].
    Ma Y; Qin M; Hu HQ; Ji G; Feng L; Gao N; Gu J; Xie BF; He JH; Sun MB
    Zhonghua Shi Yan He Lin Chuang Bing Du Xue Za Zhi; 2011 Jun; 25(3):197-200. PubMed ID: 21977591
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Safety and immunogenicity of inactivated poliovirus vaccine based on Sabin strains with and without aluminum hydroxide: a phase I trial in healthy adults.
    Verdijk P; Rots NY; van Oijen MG; Oberste MS; Boog CJ; Okayasu H; Sutter RW; Bakker WA
    Vaccine; 2013 Nov; 31(47):5531-6. PubMed ID: 24063976
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A national reference for inactivated polio vaccine derived from Sabin strains in Japan.
    Shirato H; Someya Y; Ochiai M; Horiuchi Y; Takahashi M; Takeda N; Wakabayashi K; Ouchi Y; Ota Y; Tano Y; Abe S; Yamazaki S; Wakita T;
    Vaccine; 2014 Sep; 32(40):5163-9. PubMed ID: 25090648
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Inactivated polio vaccine development for technology transfer using attenuated Sabin poliovirus strains to shift from Salk-IPV to Sabin-IPV.
    Bakker WA; Thomassen YE; van't Oever AG; Westdijk J; van Oijen MG; Sundermann LC; van't Veld P; Sleeman E; van Nimwegen FW; Hamidi A; Kersten GF; van den Heuvel N; Hendriks JT; van der Pol LA
    Vaccine; 2011 Sep; 29(41):7188-96. PubMed ID: 21651934
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Measuring Poliovirus Antigenicity by Surface Plasmon Resonance. Application for Potency Indicating Assays.
    Westdijk J; van der Maas L; Ten Have R; Kersten G
    Methods Mol Biol; 2016; 1387():299-323. PubMed ID: 26983742
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Analysis of the dose-sparing effect of adjuvanted Sabin-inactivated poliovirus vaccine (sIPV).
    Li Z; Ding W; Guo Q; Liu Z; Zhu Z; Song S; Li W; Liao G
    Hum Vaccin Immunother; 2018; 14(8):1987-1994. PubMed ID: 29601259
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Assessing the potency and immunogenicity of inactivated poliovirus vaccine after exposure to freezing temperatures.
    White JA; Estrada M; Weldon WC; Chumakov K; Kouiavskaia D; Fournier-Caruana J; Stevens E; Gary HE; Maes EF; Oberste MS; Snider CJ; Anand A; Chen D
    Biologicals; 2018 May; 53():30-38. PubMed ID: 29548791
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Analyzed immunogenicity of fractional doses of Sabin-inactivated poliovirus vaccine (sIPV) with intradermal delivery in rats.
    Ma L; Cai W; Sun M; Cun Y; Zhou J; Liu J; Hu W; Zhang X; Song S; Jiang S; Liao G
    Hum Vaccin Immunother; 2016 Dec; 12(12):3125-3131. PubMed ID: 27558963
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Development of inactivated poliovirus vaccine derived from Sabin strains.
    Simizu B; Abe S; Yamamoto H; Tano Y; Ota Y; Miyazawa M; Horie H; Satoh K; Wakabayashi K
    Biologicals; 2006 Jun; 34(2):151-4. PubMed ID: 16679028
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Thermostabilization of inactivated polio vaccine in PLGA-based microspheres for pulsatile release.
    Tzeng SY; Guarecuco R; McHugh KJ; Rose S; Rosenberg EM; Zeng Y; Langer R; Jaklenec A
    J Control Release; 2016 Jul; 233():101-13. PubMed ID: 27178811
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.